
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $71.9M | $55.3M | $51.3M | $57.4M | $64.4M | |
Revenue Growth (YoY) | -2.12% | -23.03% | -7.17% | 11.84% | 12.12% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $261M | $193.7M | $63.4M | $40.6M | $37.6M | |
Selling, General & Admin | $108.5M | $99.3M | $67.1M | $70.1M | $69.2M | |
Other Inc / (Exp) | -$1.6M | -$20.1M | -$15.9M | -$2.7M | -$4.5M | |
Operating Expenses | $369.5M | $293M | $130.5M | $110.7M | $106.8M | |
Operating Income | -$297.6M | -$237.6M | -$79.1M | -$53.3M | -$42.4M | |
Net Interest Expenses | $4.1M | $7.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$303.3M | -$265.2M | -$92.8M | -$49.3M | -$44.6M | |
Earnings of Discontinued Ops. | $16.8M | $65.6M | $965M | -- | -- | |
Income Tax Expense | -$8.5M | -$151K | $9K | $5.9M | $11.8M | |
Net Income to Company | -$294.8M | -$265.1M | -$92.8M | -$55.2M | -$56.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$278M | -$199.4M | $872.1M | -$55.2M | -$56.4M | |
Basic EPS (Cont. Ops) | -$4.46 | -$2.87 | $11.85 | -$1.00 | -$1.15 | |
Diluted EPS (Cont. Ops) | -$4.46 | -$2.87 | $11.85 | -$1.00 | -$1.15 | |
Weighted Average Basic Share | $62.3M | $69.5M | $73.6M | $55.3M | $48.8M | |
Weighted Average Diluted Share | $62.3M | $69.5M | $73.6M | $55.3M | $48.8M | |
EBITDA | -$287.8M | -$248.1M | -$79.4M | -$42.7M | -$38.5M | |
EBIT | -$294.8M | -$256.7M | -$86.4M | -$46.9M | -$42.1M | |
Revenue (Reported) | $71.9M | $55.3M | $51.3M | $57.4M | $64.4M | |
Operating Income (Reported) | -$297.6M | -$237.6M | -$79.1M | -$53.3M | -$42.4M | |
Operating Income (Adjusted) | -$294.8M | -$256.7M | -$86.4M | -$46.9M | -$42.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $14.3M | $13.2M | $10.4M | $14.5M | $15.4M | |
Revenue Growth (YoY) | -28.22% | -7.44% | -21.06% | 39.22% | 6.1% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $67.6M | $23.3M | $14.6M | $9M | $11.5M | |
Selling, General & Admin | $30.6M | $17.8M | $19.2M | $16.7M | $18.4M | |
Other Inc / (Exp) | $16.5M | -$9.3M | -$1.6M | -- | -- | |
Operating Expenses | $98.1M | $41.1M | $33.8M | $25.7M | $29.8M | |
Operating Income | -$83.9M | -$27.9M | -$23.3M | -$11.2M | -$14.4M | |
Net Interest Expenses | $12.1M | $2.5M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$79.5M | -$39.7M | -$22.5M | -$10.4M | -$14.1M | |
Earnings of Discontinued Ops. | -- | $14.3M | -- | -- | -- | |
Income Tax Expense | $227K | $524K | -$395K | $1.3M | -$559K | |
Net Income to Company | -$79.7M | -$40.3M | -$22.1M | -$11.7M | -$13.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$79.7M | -$25.9M | -$22.1M | -$11.7M | -$13.6M | |
Basic EPS (Cont. Ops) | -$1.24 | -$0.34 | -$0.35 | -$0.24 | -$0.27 | |
Diluted EPS (Cont. Ops) | -$1.24 | -$0.34 | -$0.35 | -$0.24 | -$0.27 | |
Weighted Average Basic Share | $64.5M | $75.2M | $62.9M | $48.3M | $49.7M | |
Weighted Average Diluted Share | $64.5M | $75.2M | $62.9M | $48.3M | $49.7M | |
EBITDA | -$65.1M | -$35.9M | -$21M | -$8.6M | -$12.4M | |
EBIT | -$67.3M | -$37.2M | -$21.9M | -$9.8M | -$13.5M | |
Revenue (Reported) | $14.3M | $13.2M | $10.4M | $14.5M | $15.4M | |
Operating Income (Reported) | -$83.9M | -$27.9M | -$23.3M | -$11.2M | -$14.4M | |
Operating Income (Adjusted) | -$67.3M | -$37.2M | -$21.9M | -$9.8M | -$13.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $66.3M | $54.3M | $48.6M | $61.5M | $65.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $262.5M | $149.3M | $54.7M | $35M | $40.1M | |
Selling, General & Admin | $112.8M | $86.6M | $68.4M | $67.7M | $70.8M | |
Other Inc / (Exp) | $16.9M | -$7.5M | -$8.1M | -$1.2M | -$4.5M | |
Operating Expenses | $375.3M | $235.9M | $123.1M | $102.7M | $110.9M | |
Operating Income | -$309M | -$181.6M | -$74.6M | -$41.2M | -$45.7M | |
Net Interest Expenses | $7.7M | $17.1M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$299.9M | -$206.2M | -$75.6M | -$37.2M | -$48.4M | |
Earnings of Discontinued Ops. | -- | $60.7M | $951.2M | -- | -- | |
Income Tax Expense | -$8.4M | $146K | -$403K | $7.6M | $10M | |
Net Income to Company | -$291.4M | -$225.7M | -$74.7M | -$44.8M | -$58.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$274.6M | -$145.7M | $876M | -$44.8M | -$58.3M | |
Basic EPS (Cont. Ops) | -$4.32 | -$2.05 | $11.53 | -$0.86 | -$1.18 | |
Diluted EPS (Cont. Ops) | -$4.32 | -$2.05 | $11.53 | -$0.86 | -$1.18 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$282.3M | -$180.1M | -$64.1M | -$30.3M | -$42.3M | |
EBIT | -$289.2M | -$187.7M | -$70.8M | -$34.8M | -$45.8M | |
Revenue (Reported) | $66.3M | $54.3M | $48.6M | $61.5M | $65.3M | |
Operating Income (Reported) | -$309M | -$181.6M | -$74.6M | -$41.2M | -$45.7M | |
Operating Income (Adjusted) | -$289.2M | -$187.7M | -$70.8M | -$34.8M | -$45.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $14.3M | $13.2M | $10.4M | $14.5M | $15.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $67.6M | $23.3M | $14.6M | $9M | $11.5M | |
Selling, General & Admin | $30.6M | $17.8M | $19.2M | $16.7M | $18.4M | |
Other Inc / (Exp) | $16.5M | -$9.3M | -$1.6M | -- | -- | |
Operating Expenses | $98.1M | $41.1M | $33.8M | $25.7M | $29.8M | |
Operating Income | -$83.9M | -$27.9M | -$23.3M | -$11.2M | -$14.4M | |
Net Interest Expenses | $12.1M | $2.5M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$79.5M | -$39.7M | -$22.5M | -$10.4M | -$14.1M | |
Earnings of Discontinued Ops. | -- | $14.3M | -- | -- | -- | |
Income Tax Expense | $227K | $524K | -$395K | $1.3M | -$559K | |
Net Income to Company | -$79.7M | -$40.3M | -$22.1M | -$11.7M | -$13.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$79.7M | -$25.9M | -$22.1M | -$11.7M | -$13.6M | |
Basic EPS (Cont. Ops) | -$1.24 | -$0.34 | -$0.35 | -$0.24 | -$0.27 | |
Diluted EPS (Cont. Ops) | -$1.24 | -$0.34 | -$0.35 | -$0.24 | -$0.27 | |
Weighted Average Basic Share | $64.5M | $75.2M | $62.9M | $48.3M | $49.7M | |
Weighted Average Diluted Share | $64.5M | $75.2M | $62.9M | $48.3M | $49.7M | |
EBITDA | -$65.1M | -$35.9M | -$21M | -$8.6M | -$12.4M | |
EBIT | -$67.3M | -$37.2M | -$21.9M | -$9.8M | -$13.5M | |
Revenue (Reported) | $14.3M | $13.2M | $10.4M | $14.5M | $15.4M | |
Operating Income (Reported) | -$83.9M | -$27.9M | -$23.3M | -$11.2M | -$14.4M | |
Operating Income (Adjusted) | -$67.3M | -$37.2M | -$21.9M | -$9.8M | -$13.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $81.5M | $90M | $298.2M | $39.5M | $37.8M | |
Short Term Investments | $211.5M | $83.5M | $29.3M | $62.9M | $50.6M | |
Accounts Receivable, Net | $15.9M | $14.1M | $16.8M | $17.5M | $18.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $20.4M | $10.2M | $1.5M | $2M | $73K | |
Other Current Assets | $10.4M | $8.6M | $7.7M | $11.6M | $4.2M | |
Total Current Assets | $393.3M | $249.9M | $353.5M | $133.5M | $161.1M | |
Property Plant And Equipment | $59.7M | $53.3M | $52M | $45.4M | $35.8M | |
Long-Term Investments | $12.8M | $67.5M | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $3.3M | $4.1M | $201.9M | $203.1M | $157.3M | |
Total Assets | $469.1M | $374.8M | $607.4M | $382M | $354.2M | |
Accounts Payable | $6.8M | $3.1M | $1.6M | $1.5M | $2.2M | |
Accrued Expenses | $76.1M | $37.9M | $20.4M | $12.8M | $13.3M | |
Current Portion Of Long-Term Debt | $19.3M | $16.9M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $9.9M | $503K | $6.8M | $3.9M | $10.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $123.6M | $58.6M | $28.7M | $24.8M | $32.1M | |
Long-Term Debt | $599.8M | $599.4M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $772.8M | $713.4M | $165.6M | $169M | $178.6M | |
Common Stock | $1K | $1K | $1K | -- | -- | |
Other Common Equity Adj | $47K | -- | -$15K | -$65K | $7K | |
Common Equity | -$303.8M | -$338.6M | $441.8M | $213M | $175.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$303.8M | -$338.6M | $441.8M | $213M | $175.5M | |
Total Liabilities and Equity | $469.1M | $374.8M | $607.4M | $382M | $354.2M | |
Cash and Short Terms | $292.9M | $173.5M | $327.5M | $102.4M | $88.4M | |
Total Debt | $619.2M | $616.3M | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $114M | $94.4M | $187.7M | $53.8M | $110.6M | |
Short Term Investments | $96M | $53.1M | $53.6M | $46.1M | $20.2M | |
Accounts Receivable, Net | $11.9M | $12.3M | $12.3M | $14.7M | $15.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $18.8M | $4.7M | $1.5M | $2.1M | -- | |
Other Current Assets | $10M | $4.5M | $6.3M | $7.6M | $4.1M | |
Total Current Assets | $293.1M | $204.6M | $261.3M | $124.3M | $150.3M | |
Property Plant And Equipment | $59.5M | $52.6M | $51.3M | $44.1M | $34.5M | |
Long-Term Investments | $19.4M | $94.1M | $18.8M | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $3.1M | $4M | $207.1M | $202.9M | $158.9M | |
Total Assets | $375.1M | $355.4M | $538.6M | $371.3M | $343.6M | |
Accounts Payable | $6.8M | $1.5M | $2.7M | $1.7M | $2.4M | |
Accrued Expenses | $59.1M | $29.5M | $16.1M | $9.4M | $12.4M | |
Current Portion Of Long-Term Debt | $11.7M | $9M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $1.2M | $4.1M | $7.4M | $4.1M | $10.8M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $86.5M | $44.2M | $26.2M | $21.7M | $31.5M | |
Long-Term Debt | $602.4M | $612.5M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $748.3M | $706.8M | $168M | $166.4M | $177.6M | |
Common Stock | $1K | $1K | $1K | -- | $1K | |
Other Common Equity Adj | $17K | -$28K | $51K | -$41K | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$373.2M | -$351.5M | $370.6M | $204.9M | $166M | |
Total Liabilities and Equity | $375.1M | $355.4M | $538.6M | $371.3M | $343.6M | |
Cash and Short Terms | $210M | $147.5M | $241.3M | $100M | $130.9M | |
Total Debt | $614.1M | $621.5M | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$294.8M | -$265.1M | -$92.8M | -$55.2M | -$56.4M | |
Depreciation & Amoritzation | $7M | $8.6M | $7M | $4.3M | $3.6M | |
Stock-Based Compensation | $63M | $62.1M | $39.7M | $25.4M | $21.4M | |
Change in Accounts Receivable | $6.1M | $1.8M | -$2.7M | -$689K | -$966K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$250.4M | -$207.9M | -$187M | -$27M | -$11.5M | |
Capital Expenditures | $6.6M | $3.4M | $572K | $2.5M | $332K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $10.7M | $124.5M | $1.2B | -$32.7M | $12.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $380M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$235.3M | -$10.7M | -$631.6M | -- | -- | |
Repurchase of Common Stock | -$9.7M | -$9.1M | -$132.3M | -$199.6M | -$3.1M | |
Other Financing Activities | -- | -- | $24.5M | -- | -- | |
Cash From Financing | $263.1M | $91.9M | -$758.8M | -$198.9M | -$2.5M | |
Beginning Cash (CF) | $58.9M | $82.3M | $90.8M | $299M | $40.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $23.4M | $8.5M | $208.2M | -$258.6M | -$1.7M | |
Ending Cash (CF) | $82.3M | $90.8M | $299M | $40.4M | $38.6M | |
Levered Free Cash Flow | -$257M | -$211.3M | -$187.6M | -$29.5M | -$11.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$79.7M | -$40.3M | -$22.1M | -$11.7M | -$13.6M | |
Depreciation & Amoritzation | $2.3M | $1.3M | $978K | $1.2M | $1.1M | |
Stock-Based Compensation | $15.8M | $14.5M | $7M | $5.2M | $4.9M | |
Change in Accounts Receivable | $4M | $1.8M | $4.5M | $2.8M | $53.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$69.9M | -$26.1M | -$11.2M | -$1M | $43M | |
Capital Expenditures | $1.8M | $250K | $938K | $91K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $113.7M | $31.9M | -$43M | $17M | $30.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$5.7M | -- | -- | -- | -- | |
Repurchase of Common Stock | -$5.6M | -$1.4M | -$56.2M | -$1.7M | -$874K | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$11.3M | -$1.4M | -$56.2M | -$1.7M | -$854K | |
Beginning Cash (CF) | $82.3M | $90.8M | $299M | $40.4M | $38.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $32.5M | $4.4M | -$110.5M | $14.3M | $72.8M | |
Ending Cash (CF) | $114.8M | $95.2M | $188.5M | $54.7M | $111.5M | |
Levered Free Cash Flow | -$71.6M | -$26.3M | -$12.2M | -$1.1M | $43M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$291.4M | -$225.7M | -$74.7M | -$44.8M | -$58.3M | |
Depreciation & Amoritzation | $6.9M | $7.6M | $6.7M | $4.5M | $3.5M | |
Stock-Based Compensation | $63.5M | $60.8M | $32.2M | $23.6M | $21M | |
Change in Accounts Receivable | $3.5M | -$362K | $7K | -$2.4M | $49.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$265.2M | -$164.1M | -$172.1M | -$16.8M | $32.5M | |
Capital Expenditures | $7.4M | $1.9M | $1.3M | $1.6M | $241K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $56M | $42.7M | $1.1B | $27.4M | $25.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | $5.8M | -- | -- | -- | -- | |
Repurchase of Common Stock | -$8.5M | -$4.9M | -$187.1M | -$145M | -$2.3M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$9.6M | $101.7M | -$813.6M | -$144.4M | -$1.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$218.8M | -$19.6M | $93.3M | -$133.8M | $56.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$272.6M | -$166M | -$173.4M | -$18.4M | $32.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$79.7M | -$40.3M | -$22.1M | -$11.7M | -$13.6M | |
Depreciation & Amoritzation | $2.3M | $1.3M | $978K | $1.2M | $1.1M | |
Stock-Based Compensation | $15.8M | $14.5M | $7M | $5.2M | $4.9M | |
Change in Accounts Receivable | $4M | $1.8M | $4.5M | $2.8M | $53.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$69.9M | -$26.1M | -$11.2M | -$1M | $43M | |
Capital Expenditures | $1.8M | $250K | $938K | $91K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $113.7M | $31.9M | -$43M | $17M | $30.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$5.7M | -- | -- | -- | -- | |
Repurchase of Common Stock | -$5.6M | -$1.4M | -$56.2M | -$1.7M | -$874K | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$11.3M | -$1.4M | -$56.2M | -$1.7M | -$854K | |
Beginning Cash (CF) | $82.3M | $90.8M | $299M | $40.4M | $38.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $32.5M | $4.4M | -$110.5M | $14.3M | $72.8M | |
Ending Cash (CF) | $114.8M | $95.2M | $188.5M | $54.7M | $111.5M | |
Levered Free Cash Flow | -$71.6M | -$26.3M | -$12.2M | -$1.1M | $43M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.